x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
THE SECURITIES EXCHANGE ACT OF 1934 |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from | to |
Florida | No. 59-1517485 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
Large accelerated filer x | Accelerated filer o | |
Non-accelerated filer o | Smaller reporting company o |
PAGE | |||
PART I. | |||
Item 1. | |||
Item 2. | |||
Item 3. | |||
Item 4. | |||
PART II. | |||
Item 1. | |||
Item 1A. | |||
Item 2. | |||
Item 3. | |||
Item 5. | |||
Item 6. | |||
Signatures |
March 31, 2013 | September 30, 2012 | ||||||
(in thousands) | |||||||
Assets: | |||||||
Cash and cash equivalents | $ | 2,174,149 | $ | 1,980,020 | |||
Assets segregated pursuant to regulations and other segregated assets | 3,635,430 | 2,784,199 | |||||
Securities purchased under agreements to resell and other collateralized financings | 623,966 | 565,016 | |||||
Financial instruments, at fair value: | |||||||
Trading instruments | 827,629 | 804,272 | |||||
Available for sale securities | 755,620 | 733,874 | |||||
Private equity investments | 397,715 | 336,927 | |||||
Other investments | 282,206 | 310,806 | |||||
Derivative instruments associated with offsetting matched book positions | 375,545 | 458,265 | |||||
Receivables: | |||||||
Brokerage clients, net | 2,074,469 | 2,067,117 | |||||
Stock borrowed | 146,081 | 200,160 | |||||
Bank loans, net | 8,416,245 | 7,991,512 | |||||
Brokers-dealers and clearing organizations | 304,847 | 225,306 | |||||
Loans to financial advisors, net | 424,690 | 445,497 | |||||
Other | 454,691 | 427,641 | |||||
Deposits with clearing organizations | 108,990 | 163,848 | |||||
Prepaid expenses and other assets | 671,134 | 605,566 | |||||
Investments in real estate partnerships held by consolidated variable interest entities | 282,465 | 299,611 | |||||
Property and equipment, net | 248,849 | 231,195 | |||||
Deferred income taxes, net | 165,550 | 168,187 | |||||
Goodwill and identifiable intangible assets, net | 364,874 | 361,246 | |||||
Total assets | $ | 22,735,145 | $ | 21,160,265 |
March 31, 2013 | September 30, 2012 | ||||||
($ in thousands) | |||||||
Liabilities and equity: | |||||||
Trading instruments sold but not yet purchased, at fair value | $ | 298,577 | $ | 232,436 | |||
Securities sold under agreements to repurchase | 397,712 | 348,036 | |||||
Derivative instruments associated with offsetting matched book positions, at fair value | 375,545 | 458,265 | |||||
Payables: | |||||||
Brokerage clients | 5,424,415 | 4,584,656 | |||||
Stock loaned | 300,988 | 423,519 | |||||
Bank deposits | 9,074,351 | 8,599,713 | |||||
Brokers-dealers and clearing organizations | 143,128 | 103,164 | |||||
Trade and other | 735,469 | 628,734 | |||||
Other borrowings | 180,000 | — | |||||
Accrued compensation, commissions and benefits | 621,397 | 690,654 | |||||
Loans payable of consolidated variable interest entities | 72,420 | 81,713 | |||||
Corporate debt | 1,199,259 | 1,329,093 | |||||
Total liabilities | 18,823,261 | 17,479,983 | |||||
Commitments and contingencies (see Note 16) | |||||||
Equity | |||||||
Preferred stock; $.10 par value; authorized 10,000,000 shares; issued and outstanding -0- shares | — | — | |||||
Common stock; $.01 par value; authorized 350,000,000 shares; issued 144,192,015 at March 31, 2013 and 142,853,667 at September 30, 2012 | 1,424 | 1,404 | |||||
Additional paid-in capital | 1,104,358 | 1,030,288 | |||||
Retained earnings | 2,472,960 | 2,346,563 | |||||
Treasury stock, at cost; 5,114,462 common shares at March 31, 2013 and 5,117,049 common shares at September 30, 2012 | (122,500 | ) | (118,762 | ) | |||
Accumulated other comprehensive income | 14,514 | 9,447 | |||||
Total equity attributable to Raymond James Financial, Inc. | 3,470,756 | 3,268,940 | |||||
Noncontrolling interests | 441,128 | 411,342 | |||||
Total equity | 3,911,884 | 3,680,282 | |||||
Total liabilities and equity | $ | 22,735,145 | $ | 21,160,265 |
Three months ended March 31, | Six months ended March 31, | ||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||
(in thousands, except per share amounts) | |||||||||||||||
Revenues: | |||||||||||||||
Securities commissions and fees | $ | 764,989 | $ | 558,527 | $ | 1,503,573 | $ | 1,069,861 | |||||||
Investment banking | 50,255 | 57,954 | 135,125 | 97,290 | |||||||||||
Investment advisory fees | 65,503 | 54,269 | 127,573 | 107,774 | |||||||||||
Interest | 118,032 | 108,852 | 241,158 | 210,948 | |||||||||||
Account and service fees | 88,400 | 75,855 | 176,851 | 149,865 | |||||||||||
Net trading profits | 8,128 | 12,979 | 17,467 | 22,322 | |||||||||||
Other | 74,991 | 21,417 | 106,060 | 30,610 | |||||||||||
Total revenues | 1,170,298 | 889,853 | 2,307,807 | 1,688,670 | |||||||||||
Interest expense | 27,203 | 17,916 | 55,224 | 33,956 | |||||||||||
Net revenues | 1,143,095 | 871,937 | 2,252,583 | 1,654,714 | |||||||||||
Non-interest expenses: | |||||||||||||||
Compensation, commissions and benefits | 763,047 | 596,891 | 1,525,595 | 1,138,513 | |||||||||||
Communications and information processing | 65,018 | 43,741 | 125,384 | 81,308 | |||||||||||
Occupancy and equipment costs | 38,694 | 27,231 | 78,172 | 53,168 | |||||||||||
Clearance and floor brokerage | 11,405 | 9,070 | 21,573 | 16,524 | |||||||||||
Business development | 31,488 | 27,382 | 62,117 | 55,221 | |||||||||||
Investment sub-advisory fees | 8,410 | 7,143 | 16,460 | 13,705 | |||||||||||
Bank loan loss provision | 3,737 | 5,154 | 6,660 | 12,610 | |||||||||||
Acquisition related expenses | 20,922 | 19,604 | 38,304 | 19,604 | |||||||||||
Other | 41,071 | 27,819 | 71,848 | 51,511 | |||||||||||
Total non-interest expenses | 983,792 | 764,035 | 1,946,113 | 1,442,164 | |||||||||||
Income including noncontrolling interests and before provision for income taxes | 159,303 | 107,902 | 306,470 | 212,550 | |||||||||||
Provision for income taxes | 51,057 | 42,628 | 104,330 | 86,154 | |||||||||||
Net income including noncontrolling interests | 108,246 | 65,274 | 202,140 | 126,396 | |||||||||||
Net income (loss) attributable to noncontrolling interests | 28,286 | (3,595 | ) | 36,306 | (9,798 | ) | |||||||||
Net income attributable to Raymond James Financial, Inc. | $ | 79,960 | $ | 68,869 | $ | 165,834 | $ | 136,194 | |||||||
Net income per common share – basic | $ | 0.57 | $ | 0.52 | $ | 1.19 | $ | 1.05 | |||||||
Net income per common share – diluted | $ | 0.56 | $ | 0.52 | $ | 1.17 | $ | 1.05 | |||||||
Weighted-average common shares outstanding – basic | 137,817 | 129,353 | 137,156 | 126,201 | |||||||||||
Weighted-average common and common equivalent shares outstanding – diluted | 140,722 | 130,644 | 139,669 | 126,989 | |||||||||||
Net income attributable to Raymond James Financial, Inc. | $ | 79,960 | $ | 68,869 | $ | 165,834 | $ | 136,194 | |||||||
Other comprehensive income, net of tax:(1) | |||||||||||||||
Change in unrealized losses on available for sale securities and non-credit portion of other-than-temporary impairment losses | 3,606 | 11,236 | 13,744 | 5,575 | |||||||||||
Change in currency translations and net investment hedges | (4,991 | ) | 2,525 | (8,677 | ) | 7,345 | |||||||||
Total comprehensive income | $ | 78,575 | $ | 82,630 | $ | 170,901 | $ | 149,114 | |||||||
Other-than-temporary impairment: | |||||||||||||||
Total other-than-temporary impairment, net | $ | 3,364 | $ | 10,853 | $ | 6,718 | $ | 6,666 | |||||||
Portion of recoveries recognized in other comprehensive income (before taxes) | (3,364 | ) | (12,190 | ) | (7,103 | ) | (10,099 | ) | |||||||
Net impairment losses recognized in other revenue | $ | — | $ | (1,337 | ) | $ | (385 | ) | $ | (3,433 | ) |
(1) | The components of other comprehensive income, net of tax, are attributable to Raymond James Financial, Inc. None of the components of other comprehensive income are attributable to noncontrolling interests. |
Six months ended March 31, | ||||||||
2013 | 2012 | |||||||
(in thousands, except per share amounts) | ||||||||
Common stock, par value $.01 per share: | ||||||||
Balance, beginning of year | $ | 1,404 | $ | 1,271 | ||||
Issuances of shares, registered public offering | — | 111 | (1) | |||||
Other issuances | 20 | 14 | ||||||
Balance, end of period | 1,424 | 1,396 | ||||||
Additional paid-in capital: | ||||||||
Balance, beginning of year | 1,030,288 | 565,135 | ||||||
Issuances of shares, registered public offering | — | 362,121 | (1) | |||||
Employee stock purchases | 8,936 | 5,567 | ||||||
Exercise of stock options and vesting of restricted stock units, net of forfeitures | 30,989 | 11,783 | ||||||
Restricted stock, stock option and restricted stock unit expense | 31,460 | 28,426 | ||||||
Excess tax benefit from share-based payments | 2,512 | 1,640 | ||||||
Other | 173 | 221 | ||||||
Balance, end of period | 1,104,358 | 974,893 | ||||||
Retained earnings: | ||||||||
Balance, beginning of year | 2,346,563 | 2,125,818 | ||||||
Net income attributable to Raymond James Financial, Inc. | 165,834 | 136,194 | ||||||
Cash dividends declared | (39,027 | ) | (34,318 | ) | ||||
Other | (410 | ) | (4,837 | ) | ||||
Balance, end of period | 2,472,960 | 2,222,857 | ||||||
Treasury stock: | ||||||||
Balance, beginning of year | (118,762 | ) | (95,000 | ) | ||||
Purchases/surrenders | (7,841 | ) | (18,900 | ) | ||||
Exercise of stock options and vesting of restricted stock units, net of forfeitures | 4,103 | (708 | ) | |||||
Balance, end of period | (122,500 | ) | (114,608 | ) | ||||
Accumulated other comprehensive income:(2) | ||||||||
Balance, beginning of year | 9,447 | (9,605 | ) | |||||
Net change in unrealized losses on available for sale securities and non-credit portion of other-than-temporary impairment losses, net of tax | 13,744 | 5,575 | ||||||
Net change in currency translations and net investment hedges, net of tax | (8,677 | ) | 7,345 | |||||
Balance, end of period | 14,514 | 3,315 | ||||||
Total equity attributable to Raymond James Financial, Inc. | $ | 3,470,756 | $ | 3,087,853 | ||||
Noncontrolling interests: | ||||||||
Balance, beginning of year | $ | 411,342 | $ | 324,226 | ||||
Net income (loss) attributable to noncontrolling interests | 36,306 | (9,798 | ) | |||||
Capital contributions | 14,767 | 27,383 | ||||||
Distributions | (34,627 | ) | (3,539 | ) | ||||
Consolidation of acquired entity (3) | 7,592 | — | ||||||
Other | 5,748 | (10,254 | ) | |||||
Balance, end of period | 441,128 | 328,018 | ||||||
Total equity | $ | 3,911,884 | $ | 3,415,871 |
(1) | During the six months ended March 31, 2012, in a registered public offering, 11,075,000 common shares were issued generating approximately $363 million in net proceeds (after consideration of the underwriting discount and direct expenses of the offering). |
(2) | The components of other comprehensive income are attributable to Raymond James Financial, Inc. None of the components of other comprehensive income are attributable to noncontrolling interests. |
(3) | On December 24, 2012, we acquired a 45% interest in ClariVest Asset Management, LLC, see Notes 1 and 3 for discussion. |
Six months ended March 31, | |||||||
2013 | 2012 | ||||||
(in thousands) | |||||||
Cash flows from operating activities: | |||||||
Net income attributable to Raymond James Financial, Inc. | $ | 165,834 | $ | 136,194 | |||
Net income (loss) attributable to noncontrolling interests | 36,306 | (9,798 | ) | ||||
Net income including noncontrolling interests | 202,140 | 126,396 | |||||
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operating activities: | |||||||
Depreciation and amortization | 33,011 | 20,053 | |||||
Deferred income taxes | (196 | ) | (10,033 | ) | |||
Premium and discount amortization on available for sale securities and unrealized/realized gain on other investments | (70,542 | ) | (13,425 | ) | |||
Provisions for loan losses, legal proceedings, bad debts and other accruals | 10,965 | 9,638 | |||||
Share-based compensation expense | 33,688 | 30,340 | |||||
Goodwill impairment expense | 6,933 | — | |||||
Other | 5,597 | (1,310 | ) | ||||
Net change in: | |||||||
Assets segregated pursuant to regulations and other segregated assets | (851,231 | ) | 90,319 | ||||
Securities purchased under agreements to resell and other collateralized financings, net of securities sold under agreements to repurchase | (9,274 | ) | 6,370 | ||||
Stock loaned, net of stock borrowed | (68,452 | ) | (242,949 | ) | |||
Repayments of loans (loans provided) to financial advisors | 20,807 | (12,842 | ) | ||||
Brokerage client receivables and other accounts receivable, net | (113,581 | ) | (5,811 | ) | |||
Trading instruments, net | 84,875 | 44,653 | |||||
Prepaid expenses and other assets | 39,111 | 27,713 | |||||
Brokerage client payables and other accounts payable | 867,203 | 83,022 | |||||
Accrued compensation, commissions and benefits | (70,863 | ) | (90,531 | ) | |||
Proceeds from sales of securitizations and loans held for sale, net of purchases and originations of loans held for sale | 58,329 | 9,677 | |||||
Excess tax benefits from share-based payment arrangements | (2,512 | ) | (2,210 | ) | |||
Net cash provided by operating activities | 176,008 | 69,070 | |||||
Cash flows from investing activities: | |||||||
Additions to property and equipment | (46,933 | ) | (31,182 | ) | |||
Increase in bank loans, net | (442,727 | ) | (961,708 | ) | |||
Redemptions of Federal Home Loan Bank/Federal Reserve Bank stock, net | 1,067 | (1,168 | ) | ||||
Sales (purchases) of private equity and other investments, net | 2,006 | (8,361 | ) | ||||
Purchases of available for sale securities | (62,102 | ) | (111,884 | ) | |||
Available for sale securities maturations, repayments and redemptions | 62,272 | 61,380 | |||||
Proceeds from sales of available for sale securities | 13 | — | |||||
Investments in real estate partnerships held by consolidated variable interest entities, net of other investing activity | 1,575 | 330 | |||||
Business acquisition, net of cash acquired | (6,450 | ) | — | ||||
Net cash used in investing activities | $ | (491,279 | ) | $ | (1,052,593 | ) |
Six months ended March 31, | |||||||
2013 | 2012 | ||||||
(in thousands) | |||||||
Cash flows from financing activities: | |||||||
Proceeds from borrowed funds, net | $ | 180,000 | $ | 936,783 | |||
Repayments of borrowed funds, net | (130,054 | ) | (4,704 | ) | |||
Proceeds from issuance of shares in registered public offering | — | 362,232 | |||||
Repayments of borrowings by consolidated variable interest entities which are real estate partnerships | (11,344 | ) | (11,600 | ) | |||
Proceeds from capital contributed to and borrowings of consolidated variable interest entities which are real estate partnerships | 908 | 101 | |||||
Purchase of additional equity interest in subsidiary | — | (4,017 | ) | ||||
Exercise of stock options and employee stock purchases | 44,219 | 16,144 | |||||
Increase in bank deposits | 474,638 | 174,524 | |||||
Purchase of treasury stock | (9,311 | ) | (19,222 | ) | |||
Dividends on common stock | (37,457 | ) | (32,878 | ) | |||
Excess tax benefits from share-based payment arrangements | 2,512 | 2,210 | |||||
Net cash provided by financing activities | 514,111 | 1,419,573 | |||||
Currency adjustment: | |||||||
Effect of exchange rate changes on cash | (4,711 | ) | 113 | ||||
Net increase in cash and cash equivalents | 194,129 | 436,163 | |||||
Cash and cash equivalents at beginning of year | 1,980,020 | 2,439,695 | |||||
Cash and cash equivalents at end of period | $ | 2,174,149 | $ | 2,875,858 | |||
Supplemental disclosures of cash flow information: | |||||||
Cash paid for interest | $ | 53,442 | $ | 36,311 | |||
Cash paid for income taxes | $ | 83,111 | $ | 110,488 | |||
Non-cash transfers of loans to other real estate owned | $ | 1,902 | $ | 10,954 |
Pro forma results (Unaudited): | Three months ended March 31, 2012 | Six months ended March 31, 2012 | ||||||
($ in thousands except per share amounts) | ||||||||
Total net revenues | $ | 1,119,154 | $ | 2,167,716 | ||||
Net income | $ | 75,114 | $ | 168,473 | ||||
Net income per share: | ||||||||
Basic | $ | 0.55 | $ | 1.23 | ||||
Diluted | $ | 0.54 | $ | 1.22 |
Three months ended March 31, | Six months ended March 31, | ||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||
(in thousands) | |||||||||||||||
Integration costs | $ | 13,082 | $ | — | $ | 28,618 | $ | — | |||||||
Severance | 7,658 | 3,183 | 8,057 | 3,183 | |||||||||||
Financial advisory fees | — | 7,020 | 1,176 | 7,020 | |||||||||||
Acquisition bridge financing facility fees | — | 5,684 | — | 5,684 | |||||||||||
Legal | — | 2,495 | — | 2,495 | |||||||||||
Other | 182 | 1,222 | 453 | 1,222 | |||||||||||
Total acquisition related expenses | $ | 20,922 | $ | 19,604 | $ | 38,304 | $ | 19,604 |
March 31, 2013 | September 30, 2012 | ||||||
(in thousands) | |||||||
Cash and cash equivalents: | |||||||
Cash in banks | $ | 2,170,618 | $ | 1,973,897 | |||
Money market fund investments | 3,531 | 6,123 | |||||
Total cash and cash equivalents (1) | 2,174,149 | 1,980,020 | |||||
Cash segregated pursuant to federal regulations and other segregated assets (2) | 3,635,430 | 2,784,199 | |||||
Deposits with clearing organizations (3) | 108,990 | 163,848 | |||||
$ | 5,918,569 | $ | 4,928,067 |
(1) | The total amounts presented include cash and cash equivalents of $719 million and $539 million as of March 31, 2013 and September 30, 2012, respectively, which are either held directly by RJF or are otherwise invested by one of our subsidiaries on behalf of RJF. |
(2) | Consists of cash maintained in accordance with Rule 15c3-3 of the Securities Exchange Act of 1934. RJ&A and MK & Co., as broker-dealers carrying client accounts, are subject to requirements related to maintaining cash or qualified securities in segregated reserve accounts for the exclusive benefit of their clients. Additionally, RJ Ltd. is required to hold client Registered Retirement Savings Plan funds in trust. |
(3) | Consists of deposits of cash and cash equivalents or other short-term securities held by other clearing organizations or exchanges. |
March 31, 2013 | Quoted prices in active markets for identical assets (Level 1) (1) | Significant other observable inputs (Level 2) (1) | Significant unobservable inputs (Level 3) | Netting adjustments (2) | Balance as of March 31, 2013 | |||||||||||||||
(in thousands) | ||||||||||||||||||||
Assets at fair value on a recurring basis: | ||||||||||||||||||||
Trading instruments: | ||||||||||||||||||||
Municipal and provincial obligations | $ | 1,662 | $ | 231,956 | $ | — | $ | — | $ | 233,618 | ||||||||||
Corporate obligations | 36,225 | 91,873 | — | — | 128,098 | |||||||||||||||
Government and agency obligations | 10,701 | 131,135 | — | — | 141,836 | |||||||||||||||
Agency mortgage-backed securities (“MBS”) and collateralized mortgage obligations (“CMOs”) | 931 | 206,435 | — | — | 207,366 | |||||||||||||||
Non-agency CMOs and asset-backed securities (“ABS”) | — | 15,768 | 17 | — | 15,785 | |||||||||||||||
Total debt securities | 49,519 | 677,167 | 17 | — | 726,703 | |||||||||||||||
Derivative contracts | — | 122,380 | — | (78,287 | ) | 44,093 | ||||||||||||||
Equity securities | 28,790 | 5,287 | 21 | — | 34,098 | |||||||||||||||
Other securities | 761 | 16,251 | 5,723 | — | 22,735 | |||||||||||||||
Total trading instruments | 79,070 | 821,085 | 5,761 | (78,287 | ) | 827,629 | ||||||||||||||
Available for sale securities: | ||||||||||||||||||||
Agency MBS and CMOs | — | 370,767 | — | — | 370,767 | |||||||||||||||
Non-agency CMOs | — | 143,784 | 420 | — | 144,204 | |||||||||||||||
Other securities | — | — | — | — | — | |||||||||||||||
Auction rate securities (“ARS”): | ||||||||||||||||||||
Municipals | — | — | 134,630 | (3) | — | 134,630 | ||||||||||||||
Preferred securities | — | — | 106,019 | — | 106,019 | |||||||||||||||
Total available for sale securities | — | 514,551 | 241,069 | — | 755,620 | |||||||||||||||
Private equity investments | — | — | 397,715 | (4) | — | 397,715 | ||||||||||||||
Other investments (5) | 276,505 | 1,719 | 3,982 | — | 282,206 | |||||||||||||||
Derivative instruments associated with offsetting matched book positions | — | 375,545 | — | — | 375,545 | |||||||||||||||
Other assets | — | — | 15 | — | 15 | |||||||||||||||
Total assets at fair value on a recurring basis | $ | 355,575 | $ | 1,712,900 | $ | 648,542 | $ | (78,287 | ) | $ | 2,638,730 | |||||||||
Assets at fair value on a nonrecurring basis (6): | ||||||||||||||||||||
Bank loans, net: | ||||||||||||||||||||
Impaired loans | $ | — | $ | 38,290 | $ | 57,030 | $ | — | $ | 95,320 | ||||||||||
Loans held for sale(7) | — | 8,707 | — | — | 8,707 | |||||||||||||||
Total bank loans, net | — | 46,997 | 57,030 | — | 104,027 | |||||||||||||||
Other real estate owned (“OREO”)(8) | — | 881 | — | — | 881 | |||||||||||||||
Total assets at fair value on a nonrecurring basis | $ | — | $ | 47,878 | $ | 57,030 | $ | — | $ | 104,908 | ||||||||||
(continued on next page) |
March 31, 2013 | Quoted prices in active markets for identical assets (Level 1) (1) | Significant other observable inputs (Level 2) (1) | Significant unobservable inputs (Level 3) | Netting adjustments (2) | Balance as of March 31, 2013 | |||||||||||||||
(in thousands) | ||||||||||||||||||||
(continued from previous page) | ||||||||||||||||||||
Liabilities at fair value on a recurring basis: | ||||||||||||||||||||
Trading instruments sold but not yet purchased: | ||||||||||||||||||||
Municipal and provincial obligations | $ | 406 | $ | 2,690 | $ | — | $ | — | $ | 3,096 | ||||||||||
Corporate obligations | 1,013 | 24,976 | — | — | 25,989 | |||||||||||||||
Government obligations | 243,434 | — | — | — | 243,434 | |||||||||||||||
Agency MBS and CMOs | 369 | — | — | — | 369 | |||||||||||||||
Non-agency MBS and CMOs | — | — | — | — | — | |||||||||||||||
Total debt securities | 245,222 | 27,666 | — | — | 272,888 | |||||||||||||||
Derivative contracts | — | 106,762 | — | (102,931 | ) | 3,831 | ||||||||||||||
Equity securities | 21,513 | 342 | — | — | 21,855 | |||||||||||||||
Other securities | — | 3 | — | — | 3 | |||||||||||||||
Total trading instruments sold but not yet purchased | 266,735 | 134,773 | — | (102,931 | ) | 298,577 | ||||||||||||||
Derivative instruments associated with offsetting matched book positions | — | 375,545 | — | — | 375,545 | |||||||||||||||
Trade and other payables: | ||||||||||||||||||||
Derivative contracts | — | 671 | — | — | 671 | |||||||||||||||
Other liabilities | — | — | 98 | — | 98 | |||||||||||||||
Total trade and other payables | — | 671 | 98 | — | 769 | |||||||||||||||
Total liabilities at fair value on a recurring basis | $ | 266,735 | $ | 510,989 | $ | 98 | $ | (102,931 | ) | $ | 674,891 |
(1) | We had $105 thousand in transfers of financial instruments from Level 1 to Level 2 during the three and six months ended March 31, 2013. These transfers were a result of a decrease in availability and reliability of the observable inputs utilized in the respective instruments’ fair value measurement. We had $11 thousand in transfers of financial instruments from Level 2 to Level 1 during the three months ended March 31, 2013 and $168 thousand in transfers of financial instruments from Level 2 to Level 1 during the six months ended March 31, 2013. These transfers were a result of an increase in availability and reliability of the observable inputs utilized in the respective instruments’ fair value measurement. Our policy is that the end of each respective quarterly reporting period determines when transfers of financial instruments between levels are recognized. |
(2) | Where permitted, we have elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. |
(3) | Includes $54 million of Jefferson County, Alabama Limited Obligation School Warrants ARS and $25 million of Jefferson County, Alabama Sewer Revenue Refunding Warrants ARS. |
(4) | Includes $290 million in private equity investments, the weighted-average portion we own is approximately 27%. Our indirect investment in Albion Medical Holdings, Inc. (“Albion”) in the amount of $169 million is included in this balance, the portion of which we own is $36 million as of March 31, 2013. Effectively, the economics associated with the portions of these investments we do not own become a component of noncontrolling interests on our Condensed Consolidated Statements of Financial Condition, and amounted to approximately $211 million of that total as of March 31, 2013. |
(5) | Other investments include $172 million of financial instruments we hold that are related to MK & Co.’s obligations to perform under certain of its deferred compensation plans (see Note 2 page 114, and Note 23 page 170, of our 2012 Form 10-K for further information regarding these plans). |
(6) | Goodwill fair value measurements are classified within Level 3 of the fair value hierarchy, which are generally determined using unobservable inputs. See Note 10 for additional information regarding the annual impairment analysis and our methods of estimating the fair value of reporting units that have an allocation of goodwill, including the key assumptions. |
(7) | Includes individual loans classified as held for sale, which were recorded at a fair value lower than cost. |
(8) | Represents the fair value of foreclosed properties which were measured at a fair value subsequent to their initial classification as OREO. The recorded value in the Condensed Consolidated Statements of Financial Condition is net of the estimated selling costs. |
September 30, 2012 | Quoted prices in active markets for identical assets (Level 1) (1) | Significant other observable inputs (Level 2) (1) | Significant unobservable inputs (Level 3) | Netting adjustments (2) | Balance as of September 30, 2012 | |||||||||||||||
(in thousands) | ||||||||||||||||||||
Assets at fair value on a recurring basis: | ||||||||||||||||||||
Trading instruments: | ||||||||||||||||||||
Municipal and provincial obligations | $ | 7 | $ | 346,030 | $ | 553 | $ | — | $ | 346,590 | ||||||||||
Corporate obligations | 15,916 | 70,815 | — | — | 86,731 | |||||||||||||||
Government and agency obligations | 10,907 | 156,492 | — | — | 167,399 | |||||||||||||||
Agency MBS and CMOs | 1,085 | 104,084 | — | — | 105,169 | |||||||||||||||
Non-agency CMOs and ABS | — | 1,986 | 29 | — | 2,015 | |||||||||||||||
Total debt securities | 27,915 | 679,407 | 582 | — | 707,904 | |||||||||||||||
Derivative contracts | — | 144,259 | — | (93,259 | ) | 51,000 | ||||||||||||||
Equity securities | 23,626 | 2,891 | 6 | — | 26,523 | |||||||||||||||
Other securities | 864 | 12,131 | 5,850 | — | 18,845 | |||||||||||||||
Total trading instruments | 52,405 | 838,688 | 6,438 | (93,259 | ) | 804,272 | ||||||||||||||
Available for sale securities: | ||||||||||||||||||||
Agency MBS and CMOs | — | 352,303 | — | — | 352,303 | |||||||||||||||
Non-agency CMOs | — | 147,558 | 249 | — | 147,807 | |||||||||||||||
Other securities | 12 | — | — | — | 12 | |||||||||||||||
ARS: | ||||||||||||||||||||
Municipals | — | — | 123,559 | (3) | — | 123,559 | ||||||||||||||
Preferred securities | — | — | 110,193 | — | 110,193 | |||||||||||||||
Total available for sale securities | 12 | 499,861 | 234,001 | — | 733,874 | |||||||||||||||
Private equity investments | — | — | 336,927 | (4) | — | 336,927 | ||||||||||||||
Other investments (5) | 303,817 | 2,897 | 4,092 | — | 310,806 | |||||||||||||||
Derivative instruments associated with offsetting matched book positions | — | 458,265 | — | — | 458,265 | |||||||||||||||
Total assets at fair value on a recurring basis | $ | 356,234 | $ | 1,799,711 | $ | 581,458 | $ | (93,259 | ) | $ | 2,644,144 | |||||||||
Assets at fair value on a nonrecurring basis: | ||||||||||||||||||||
Bank loans, net | ||||||||||||||||||||
Impaired loans(6) | — | 47,409 | 46,383 | — | 93,792 | |||||||||||||||
Loans held for sale(7) | — | 81,093 | — | — | 81,093 | |||||||||||||||
Total bank loans, net | — | 128,502 | 46,383 | — | 174,885 | |||||||||||||||
OREO(8) | — | 6,216 | — | — | 6,216 | |||||||||||||||
Total assets at fair value on a nonrecurring basis | $ | — | $ | 134,718 | $ | 46,383 | $ | — | $ | 181,101 | ||||||||||
(continued on next page) |
September 30, 2012 | Quoted prices in active markets for identical assets (Level 1) (1) | Significant other observable inputs (Level 2) (1) | Significant unobservable inputs (Level 3) | Netting adjustments (2) | Balance as of September 30, 2012 | |||||||||||||||
(in thousands) | ||||||||||||||||||||
(continued from previous page) | ||||||||||||||||||||
Liabilities at fair value on a recurring basis: | ||||||||||||||||||||
Trading instruments sold but not yet purchased: | ||||||||||||||||||||
Municipal and provincial obligations | $ | — | $ | 212 | $ | — | $ | — | $ | 212 | ||||||||||
Corporate obligations | 33 | 12,355 | — | — | 12,388 | |||||||||||||||
Government obligations | 199,501 | 587 | — | — | 200,088 | |||||||||||||||
Agency MBS and CMOs | 556 | — | — | — | 556 | |||||||||||||||
Non-agency MBS and CMOs | — | 121 | — | — | 121 | |||||||||||||||
Total debt securities | 200,090 | 13,275 | — | — | 213,365 | |||||||||||||||
Derivative contracts | — | 128,081 | — | (124,979 | ) | 3,102 | ||||||||||||||
Equity securities | 9,636 | 64 | — | — | 9,700 | |||||||||||||||
Other securities | — | 6,269 | — | — | 6,269 | |||||||||||||||
Total trading instruments sold but not yet purchased | 209,726 | 147,689 | — | (124,979 | ) | 232,436 | ||||||||||||||
Derivative instruments associated with offsetting matched book positions | — | 458,265 | — | — | 458,265 | |||||||||||||||
Trade and other payables: | ||||||||||||||||||||
Derivative contracts | — | 1,370 | — | — | 1,370 | |||||||||||||||
Other liabilities | — | — | 98 | — | 98 | |||||||||||||||
Total trade and other payables | — | 1,370 | 98 | — | 1,468 | |||||||||||||||
Total liabilities at fair value on a recurring basis | $ | 209,726 | $ | 607,324 | $ | 98 | $ | (124,979 | ) | $ | 692,169 |
(1) | We had no transfers of financial instruments from Level 1 to Level 2 during the year ended September 30, 2012. We had $541 thousand in transfers of financial instruments from Level 2 to Level 1 during the year ended September 30, 2012. These transfers were a result of an increase in availability and reliability of the observable inputs utilized in the respective instruments’ fair value measurement. Our policy is that the end of each respective quarterly reporting period determines when transfers of financial instruments between levels are recognized. |
(2) | Where permitted, we have elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. |
(3) | Includes $48 million of Jefferson County, Alabama Limited Obligation School Warrants ARS and $22 million of Jefferson County, Alabama Sewer Revenue Refunding Warrants ARS. |
(4) | Includes $224 million in private equity investments of which the weighted-average portion we own is approximately 28%. Effectively, the economics associated with the portions of these investments we do not own become a component of noncontrolling interests on our Condensed Consolidated Statements of Financial Condition, and amounted to approximately $161 million of that total as of September 30, 2012. |
(5) | Other investments include $185 million of financial instruments we hold that are related to MK & Co.’s obligations to perform under certain of its deferred compensation plans (see Note 2 page 114, and Note 23, page 170, of our 2012 Form 10-K for further information regarding these plans). |
(6) | During the year ended September 30, 2012, we initially transferred $55 million of impaired loans from Level 3 to Level 2. The transfer was a result of the increase in availability and reliability of the observable inputs utilized in the respective instruments’ fair value measurement. Our analysis indicates that comparative sales data is a reasonable estimate of fair value, therefore, more consideration was given to this observable input. |
(7) | Includes individual loans classified as held for sale, which were recorded at a fair value lower than cost. |
(8) | Represents the fair value of foreclosed properties which were measured at a fair value subsequent to their initial classification as OREO. The recorded value in the Condensed Consolidated Statements of Financial Condition is net of the estimated selling costs. |
Three months ended March 31, 2013 Level 3 assets at fair value (in thousands) | |||||||||||||||||||||||||||||||||||||||
Financial assets | Financial liabilities | ||||||||||||||||||||||||||||||||||||||
Trading instruments | Available for sale securities | Private equity, other investments and other assets | Payables- trade and other | ||||||||||||||||||||||||||||||||||||
Non- agency CMOs & ABS | Equity securities | Other securities | Non- agency CMOs | ARS – municipals | ARS - preferred securities | Private equity investments | Other investments | Other assets | Other liabilities | ||||||||||||||||||||||||||||||
Fair value December 31, 2012 | $ | 18 | $ | 19 | $ | 6,451 | $ | 125 | $ | 133,318 | $ | 104,976 | $ | 329,767 | $ | 4,123 | $ | — | $ | (98 | ) | ||||||||||||||||||
Total gains (losses) for the period: | |||||||||||||||||||||||||||||||||||||||
Included in earnings | 4 | — | (20 | ) | — | 9 | — | 63,033 | (1) | 17 | — | — | |||||||||||||||||||||||||||
Included in other comprehensive income | — | — | — | 310 | 1,328 | 1,043 | — | — | — | — | |||||||||||||||||||||||||||||
Purchases and contributions | — | — | 1,937 | — | — | — | 7,060 | — | — | — | |||||||||||||||||||||||||||||
Sales | — | — | (2,005 | ) | — | — | — | — | (50 | ) | — | — | |||||||||||||||||||||||||||
Redemptions by issuer | — | — | — | — | (25 | ) | — | — | — | — | — | ||||||||||||||||||||||||||||
Distributions | (5 | ) | — | (625 | ) | (15 | ) | — | — | (2,145 | ) | (108 | ) | — | — | ||||||||||||||||||||||||
Transfers: (2) | |||||||||||||||||||||||||||||||||||||||
Into Level 3 | — | 2 | — | — | — | — | — | — | 15 | — | |||||||||||||||||||||||||||||
Out of Level 3 | — | — | (15 | ) | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||
Fair value March 31, 2013 | $ | 17 | $ | 21 | $ | 5,723 | $ | 420 | $ | 134,630 | $ | 106,019 | $ | 397,715 | $ | 3,982 | $ | 15 | $ | (98 | ) | ||||||||||||||||||